• Home
  • Biopharmaceutical Research Services
  • Multi-Omics Services
  • Support
  • /assets/images/icon/icon-email-2.png

    Email:

    info@MtoZ-Biolabs.com

    De Novo Sequencing Using Mass Spectrometry

      De Novo sequencing using mass spectrometry is a pivotal technique for elucidating the amino acid sequences of proteins and peptides. By accurately measuring the mass-to-charge ratios of ionized molecules or molecular fragments, mass spectrometry provides detailed insights into their composition and structure. Typically, De Novo sequencing incorporates liquid chromatography-tandem mass spectrometry (LC-MS/MS) for the efficient separation and analysis of complex biological samples. This methodology is especially crucial for identifying previously unknown proteins in newly discovered organisms or non-sequenced genomes, where bioactive proteins may remain undetected. One significant application of this approach is the comprehensive analysis of novel or variant proteins, which holds substantial promise in identifying disease-relevant biomarkers, studying intricate post-translational modifications, and elucidating protein interaction networks. In oncology, for example, de novo sequencing using mass spectrometry can pinpoint mutant proteins implicated in tumorigenesis, thereby informing personalized therapeutic strategies. In the biopharmaceutical domain, this technique aids in the precise analysis and optimization of therapeutic proteins and antibodies, ensuring their quality and purity. Additionally, in agricultural biotechnology, this approach facilitates the development of crops with enhanced traits.

       

      Technical Process of De Novo Sequencing Using Mass Spectrometry

      1. Sample Preparation and Enzymatic Digestion

      The initial phase of De Novo sequencing involves preparing the protein or peptide samples, typically through enzymatic digestion to yield smaller, more analyzable fragments. Trypsin is the enzyme of choice, specifically cleaving at lysine and arginine residues, thus generating peptides conducive to detailed analysis. This step enhances the sensitivity and sequence coverage in mass spectrometric examination.

       

      2. Mass Spectrometry Analysis and Data Acquisition

      Following sample preparation, the core component of the process is mass spectrometry analysis. Employing liquid chromatography, the mixture is separated, allowing the mass spectrometer to analyze each peptide sequentially. Ionization is achieved via electrospray ionization (ESI) or matrix-assisted laser desorption/ionization (MALDI), followed by mass analysis. Fragmentation data are then obtained through procedures such as collision-induced dissociation (CID) or higher-energy collisional dissociation (HCD), leading to the determination of peptide sequences through computational algorithms.

       

      Advantages and Challenges of De Novo Sequencing Using Mass Spectrometry

      1. Advantages

      De Novo sequencing using mass spectrometry boasts exceptional sensitivity and resolution, capable of detecting low-abundance proteins even within complex samples, thus facilitating the examination of proteins expressed at low levels. Advances in high-resolution mass spectrometry (HRMS) have further refined the precision of sequencing, ensuring reliable sequence analysis.

       

      2. Challenges and Solutions

      Despite the numerous advantages of De Novo sequencing using mass spectrometry, the technique faces challenges, primarily in data analysis due to the large volume of complex data and potential noise interference. To address these issues, advanced algorithms and software tools are being developed to enhance the speed and accuracy of sequence identification. Additionally, sample complexity and post-translational modifications (PTMs) can complicate sequence interpretation. Therefore, strategic approaches in both sample preparation and data analysis are essential to mitigate these challenges. MtoZ Biolabs offers expert technical support and comprehensive services, leveraging extensive expertise to deliver high-quality De Novo sequencing solutions, thereby supporting scientific research and industrial applications. Partnering with MtoZ Biolabs ensures reliable technical support and an exceptional customer experience.

       

      MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.

      Related Services

      De Novo Sequencing Service

    Submit Inquiry
    Name *
    Email Address *
    Phone Number
    Inquiry Project
    Project Description *

     

    How to order?


    /assets/images/icon/icon-message.png

    Submit Inquiry

    /assets/images/icon/icon-return.png